Neutrophil-to-lymphocyte ratio indicative of periprosthetic joint infection after joint replacement: Study
Canada: Neutrophil to lymphocyte ratio (NLR) can be a valuable triage test for the diagnosis of periprosthetic joint infection (PJI) after total joint arthroplasty (TJA) because it is cost-effective and readily available, a recent retrospective cohort study has shown.
"The study revealed significantly higher NLR levels in patients with PJI, particularly at the time of revision surgery compared to index surgery (6.89 vs. 2.85)," the researchers reported. "The mean NLR was markedly higher in patients undergoing revision for PJI (6.89) than in aseptic revisions (3.17)."
The findings were published online in the Journal of the American Academy of Orthopaedic Surgeons on March 15, 2024.
Periprosthetic joint infection following total joint arthroplasty is a severe complication posing notable clinical implications for patients and substantial economic burdens. The neutrophil-to-lymphocyte ratio is an emerging biomarker of inflammation, which may better predict PJI.
Against the above background, Thomas J. Wood, McMaster University, Hamilton, ON, Canada, and colleagues aimed to evaluate NLR changes in patients with confirmed PJI. They also compared NLR between an aseptic revision and a revision for PJI and established whether an NLR of 2.45 is an appropriate cutoff for predicting infection.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.